NFKB1 and hepatocellular carcinoma: By checking the protein expression, we noted that the NFκB signaling pathway, but not Akt/mTOR, ERK1/2, JNK or p38 signaling pathways, was significantly inhibited by desloratadine in HCC cells (Fig. 5g and Supplementary Fig. 6b).